EGFR/BRAF, EFRF/KRAS, KRAS/ERBB2 demonstrated a mutually exclusive relationship, consistent with the recent evidence from cancer genomic studies which demonstrated that driver genes are often mutated in a mutually exclusive manner (36). This evidence concerns the gene KRAS and cancer.